Registration coming soon!

We are turning 10!

Join us for a reception on November 30 at the Grand Concourse to see how far we've come with your support ... and just how far we plan to go.

Events Search and Views Navigation

Event Views Navigation

Today

Monitoring HCV During Pregnancy

Virtual , United States

Virtual by Zoom Presented by Dr. Yasaswi Kislovskiy AHN Register online here!   *** Industry partners must have an exhibit or sponsorship to participate in the Community Liver Alliance programs […]

PBC Update

PBC Update Virtual Program for Patients & Caregivers October 16, 2023 6:00-8:00 p.m. EST Expert speaker: Alex Myint, MD Transplant Hepatology, UPMC Center for Liver Diseases The interactive program includes […]

Virtual Liver Cancer Provider Conference

Virtual , United States

Annual Liver Cancer Conference October 28, 2023 8:15 a.m. – 3:00 p.m. ET Virtual & Free Event! Click here to register!   *Industry partners must have an exhibit or sponsorship to participate […]

Treating HCV in a Primary Care Setting

Virtual , United States

Hosted by Matthew Barnes, CRNP Crossroads Treatment Center   Virtual via Zoom - Register now!   *** Industry partners must have an exhibit or sponsorship to participate in the Community […]

HCV Provider Networking Meeting

Virtual , United States

Opportunities to discuss what is new in the Hep C space with other professionals.  Each meeting we will focus on one particular organization and their work, with a collaborative discussion […]

Advocacy

Learn More

News & Information

News & Information

Seniors

Improving Seniors Timely Access to Care

Improving Seniors Timely Access to Care H.R. 3107, Care Act of 2019 CLA cosponsored legislation that streamlined and standardized the Prior Authorization (PA) process under Medicare Advantage (MA). PA is

Read More »
November 17, 2019

Suzanna Masartis Speaks Out for Hep C

Testimony of Suzanna Masartis Executive Director, Community Liver Alliance Joint Informational Meeting of the Pennsylvania House Health and Insurance Committees Monday, April 20, 2015 My name is Suzanna Masartis and

Read More »
October 28, 2021

Advocacy

Liver Disease Does Not Discriminate
There is 80 to 100 million people in the USA that have Fatty Liver Disease and most do not even know they have it. Liver Disease does not discriminate. It affects any age, social economics and race. Liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time.
COVID-19 Response
Ensure funding for COVID-19 and liver disease public health programs, research, vaccine dissemination; ensure that people living with liver disease are not disproportionately impacted and do not experience unnecessary or discriminatory health care or treatment disruptions.
Health Disparities
Address inequities in the care of people impacted by liver disease, especially the excess incidence rate of liver cancer in black men in America.
Liver Health Policy
Advance the U.S. NASH Action Plan, and ensure patients with liver disease perspectives are represented in relevant legislative packages: COVID-19, diabetes, and obesity.
Liver Health Regulations
Work with regulators to establish logical pathways to consistently approve therapies for liver diseases, particularly rare liver diseases.
Research Funding
Advocate for funding that ensures meaningful growth of vital liver disease research and the improving of liver health.
Transplant
Urgently respond to the inequities that impact organ transplantation; modernize the U.S. Organ Donation system, improve care for transplant patients, and increase the number of available organs.
Viral Hepatitis
Increase support for hepatitis programs and raise awareness of viral hepatitis; advocate for the elimination of viral hepatitis .
Value
Advance health care policies that reflect each person’s unique needs and drive access to personalized, patient-centric care.
Patient Access and Reimbursement
Support policy solutions that curb patients’ health care expenses; advocate for the smoothing and capping of out-of-pocket costs in Medicare Part D.
Previous
Next
Learn More
0
PEOPLE IN USA WITH LIVER DISEASE
0
PEOPLE IN USA WITH FATTY LIVER DISEASE
0 %
RISE IN LIVER CANCER SINCE 1980
thumbnail_candy
a5b522_bb2badba75194f0ca50fa9f4b1eb9bd3_mv2_d_5184_3456_s_4_2 (1)
a5b522_3be131b09ce34a6381cb85f997038b37_mv2_d_4000_3000_s_4_2
CLA Event 4
CLA Event 2
CLA Event 3
CLA Event 1
20220727_125343